CoChat

On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis

Papadopoulos, Vassilios · 2014 · Endocrinology
Cited by 46

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Morohaku et al (1) report that the translocator protein (18-kDa) TSPO, previously known as peripheral-type benzodiazepine receptor, is not required for steroid hormone biosynthesis. The study was based on analysis of a conditional knockout of TSPO in Leydig and Sertoli cells. The findings were surprising and were coupled to a definitive statement implying that what was suggested for Leydig cells is the case for all steroid-synthesizing cells in the body (1). To understand the reported findings and place them within the context of the TSPO and steroidogenesis literature, I will try to address five questions: 1) What are the complexities of cholesterol mobilization and transport? 2) What are the data indicating that TSPO is integrally involved in steroid formation? 3) Are there limitations of the Morohaku paper? 4) Where do the discrepancies lie? and 5) Where do we go from here? The adrenal, gonads, placenta, and brain are the major tissues that are able to make steroids from the precursor cholesterol (2, 3). In the past 2 decades, thymus and skin also have been identified as having this ability (4, 5). Adrenal and gonadal steroidogenesis is under hormonal control; placental steroidogenesis is temporal and hormone independent. At yet, no hormone has been identified that induces brain steroid hormone formation. Steroidogenesis involves the metabolism of a series of substrates, the first being cholesterol, by enzymes distributed in the mitochondria and endoplasmic reticulum (2). The first step occurs in mitochondria where the enzyme cytochrome P450 (CYP)11A1 is localized in the matrix side of the inner mitochondrial membrane (IMM). Cholesterol is a highly lipophilic compound that cannot freely diffuse to IMM. Thus, there are mechanisms facilitating its movement from various intracellular stores to the outer mitochondrial membrane (OMM) where it stays segregated from the structural cholesterol, its translocation from OMM to IMM, and subsequent loading onto CYP11A1. In the adrenal and gonads, cholesterol translocation is induced by hormones and is limiting, controlling the availability of cholesterol to CYP11A1. For more than 50 years, there has been intense research to identify a single hormone-inducible protein that would be capable of binding and transferring cholesterol from intracellular stores to OMM, moving cholesterol from OMM to IMM across the aqueous intermembrane space, and loading cholesterol onto CYP11A1. No one protein has been identified that carries out all of these steps, but proteins have been identified which, functioning together in a complementary manner and within a large protein complex, are able to accomplish many of these functions. These include the steroidogenic acute regulatory protein, TSPO, and voltage-dependent anion channel (VDAC)1, among others (6–8). Snyder and colleagues (9) demonstrated the wide distribution of TSPO throughout the body, its abundance in steroid-producing cells of the adrenal and testis, and its localization at OMM. The findings that hypophysectomy, but not adrenalectomy or castration, controlled the expression of TSPO in the testis and adrenal, respectively, suggested the hormonal regulation of TSPO and its possible relationship to testicular and adrenal steroidogenesis (10). The identification of a natural polypeptide des-(Gly-Ile)-endozepine, also known as diazepam-binding inhibitor (DBI), which was able to stimulate cholesterol transport in isolated mitochondria and to bind TSPO, brought together the fields of steroidogenesis and TSPO (11, 12). These findings led to studies of the stimulatory effects of well-characterized TSPO-binding compounds on corticosteroid and androgen formation by adrenal cortical and testicular Leydig cells, respectively (13–15). Indeed, significant, 1.5- to 3.0-fold stimulation of basal steroid synthesis was found by all steroidogenic cells tested, including primary cells as well as cell lines, and also isolated mitochondria. Moreover, TSPO functional antagonists and partial agonists were able to block hormone- and TSPO ligand-induced steroid formation in both primary cells and cell lines (16–18). Consistent with this, DBI was shown to increase steroid formation when applied to isolated mitochondria, whereas its knockdown blocked steroidogenesis in Leydig cell lines (13). Interestingly, DBI levels in Leydig cells were reduced in hypophysectomized animals (19), and 2 knockout DBI (ACBD1/ACBP) mouse models resulted either in a lethal phenotype (20) or metabolic defects (21). TSPO was pharmacologically and biochemically characterized, its topography in OMM established, and its ability to move cholesterol through the OMM demonstrated in silico (22–24). TSPO was then shown to be a high-affinity cholesterol-binding protein, and mutations in its cholesterol recognition amino acid consensus domain were shown to eliminate its ability to bind cholesterol (25). Knocking down TSPO in various cell lines led to cell death, most likely because of

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2013-2033

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 46

Metadata

Authors
Papadopoulos, V.
Venue
Endocrinology
Published
2014-01-01
Volume
155
Issue
1
Pages
15-20
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2034821245
Cited by
46
References
13
FWCI
3.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis. https://app.cochat.ai/papers/10.1210/en.2013-2033
The paper
Papadopoulos, V. (2014). On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis. Endocrinology. https://doi.org/10.1210/en.2013-2033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.